HOOKIPA PHARMA INC. Lease, Cost
HOOKIPA PHARMA INC. reported Lease, Cost of $1.70 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2025-02-28
- HOOKIPA PHARMA INC. lease, cost for the quarter ending 2020-03-31 was $558.00K, a 50.81% increase year-over-year.
- HOOKIPA PHARMA INC. lease, cost for the quarter ending 2019-12-31 was $548.00K.
- HOOKIPA PHARMA INC. lease, cost for the quarter ending 2019-09-30 was $567.00K.
- HOOKIPA PHARMA INC. lease, cost for the quarter ending 2019-06-30 was $558.00K.
- HOOKIPA PHARMA INC. lease, cost for fiscal 2024 was $1.70M, a 6.67% increase from fiscal 2023.
- HOOKIPA PHARMA INC. lease, cost for fiscal 2023 was $1.59M, a 8.57% decline from fiscal 2022.
- HOOKIPA PHARMA INC. lease, cost for fiscal 2022 was $1.74M, a 30.76% decline from fiscal 2021.
- HOOKIPA PHARMA INC. lease, cost for fiscal 2021 was $2.51M, a 9.18% increase from fiscal 2020.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2024-12-31 | $1.70M 10-K · filed 2025-02-28 | |||
| 2023-12-31 | $1.59M 10-K · filed 2025-02-28 | |||
| 2022-12-31 | $1.74M 10-K · filed 2025-02-28 | |||
| 2021-12-31 | $2.51M 10-K · filed 2024-03-22 | |||
| 2020-12-31 | $2.30M 10-K · filed 2023-03-15 | |||
| 2020-03-31 | $558.00K 10-Q · filed 2020-05-14 | $1.11M derived: sum of 2 quarters · filed 2021-03-18 | $1.67M derived: sum of 3 quarters · filed 2021-03-18 | $2.23M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-12-31 | $548.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $1.11M derived: sum of 2 quarters · filed 2021-03-18 | $1.67M derived: sum of 3 quarters · filed 2021-03-18 | $2.06M 10-K · filed 2021-03-18 |
| 2019-09-30 | $567.00K 10-Q · filed 2019-11-12 | $1.13M derived: sum of 2 quarters · filed 2019-11-12 | $1.52M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $558.00K 10-Q · filed 2019-08-12 | $930.00K 10-Q · filed 2019-08-12 | ||
| 2019-03-31 | $370.00K 10-Q · filed 2019-05-20 |